国际生殖健康/计划生育杂志

国际生殖健康/计划生育 ›› 2011, Vol. 30 ›› Issue (6): 448-453.

• 综述 • 上一篇    下一篇

中期妊娠引产的有效性和安全性

侯淑萍,程利南   

  1. 200233 上海交通大学医学院附属第六人民医院妇产科（侯淑萍）；上海市计划生育科学研究所，世界卫生组织人类生殖研究合作中心（程利南）
  • 收稿日期:1900-01-01 修回日期:1900-01-01 出版日期:2011-11-15 发布日期:2011-11-15

Effectiveness and Safety of the Termination of Midtrimester Pregnancy

HOU Shu-ping， CHENG Li-nan   

  1. Department of Gynecology and Obstetrics， The Sixth People’s Hospital， Shanghai Jiao Tong University School of Medicine， Shanghai 200233， China（HOU Shu-ping）； WHO Collaborating Center for Research in Human Reproduction， Shanghai Institute of Planned Parenthood Research， Shanghai 200032， China（CHENG Li-nan）
  • Received:1900-01-01 Revised:1900-01-01 Published:2011-11-15 Online:2011-11-15

PDF (PC)

7210

摘要： 全世界每年有较多的非意愿性妊娠流产发生，而中期妊娠流产造成2/3的重大流产并发症。医生的经验和技术水平以及妊娠妇女的知情选择，使目前常用终止中期妊娠的药物和手术方法均是安全和有效的。大部分妇女采用米非司酮配伍米索前列醇引产时不需行常规的清宫术。在某些缺乏米非司酮的

关键词: 妊娠中期, 引产, 米非司酮, 米索前列醇, 依沙吖啶

Abstract: Many pregnancies end in induced abortion worldwide each year. Midtrimester induced abortion is responsible for two?-thirds of all major complications. Both skilled doctors and pregnant women with the informed consent make the midtrimester induce abortion more effective and safe. Most of the induced abortion with mifepristone plus misoprostol do not need a routine post-abortion curettage. Intro-amniotic injection with ethacridine lactate is an alternative in the country or area where mifepristone is either unaffordable or unavailable should be close supervise the abortion procedure for women with prior uterine scar to have the midtrimester pregnant termination to avoid abortion complication.

Key words: Pregnancy trimester, second, Labor, induced, Mifepristone, Misoprostol, Ethacridine